Terveystalo Oyj (HEL:TTALO)
Finland · Delayed Price · Currency is EUR | Market Cap | 771.00M -34.8% |
| Revenue (ttm) | 1.19B -8.3% |
| Net Income | 57.20M -37.0% |
| EPS | 0.45 -37.2% |
| Shares Out | 126.81M |
| PE Ratio | 13.50 |
| Forward PE | 9.54 |
| Dividend | 0.64 (10.53%) |
| Ex-Dividend Date | Oct 7, 2026 |
| Volume | 214,260 |
| Open | 6.05 |
| Previous Close | 6.05 |
| Day's Range | 6.03 - 6.17 |
| 52-Week Range | 5.93 - 10.42 |
| Beta | 0.35 |
| Analysts | Hold |
| Price Target | 7.17 (+17.88%) |
| Earnings Date | Oct 21, 2026 |
About Terveystalo Oyj
Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral health, social, ER, well-being, and primary healthcare and specialty care services, as well as imaging and laboratory tests. It also provides remote and di... [Read more]
Financial Performance
In 2025, Terveystalo Oyj's revenue was 1.28 billion, a decrease of -4.56% compared to the previous year's 1.34 billion. Earnings were 92.60 million, an increase of 29.15%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for TTALO stock is "Hold." The 12-month stock price target is €7.17, which is an increase of 17.88% from the latest price.
News
Terveystalo Oyj Earnings Call Transcript: Q3 2026
Q3 demand weakness drove a ~6% revenue decline and lower EBIT, while dental growth and cost actions provided support. FY 2026 adjusted operating profit guidance is EUR 110–120 million, with no material Q4 market recovery assumed.
Terveystalo Oyj Quarterly report: Q3 2026
Terveystalo Oyj has published its Q3 2026 quarterly earnings report on October 21, 2026.
Terveystalo Oyj Slides: Q3 2026
Terveystalo Oyj has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 21, 2026.
Terveystalo Oyj Slides: Investor presentation
Terveystalo Oyj has posted slides in relation to its latest quarterly earnings report, which was published on September 8, 2026.
Terveystalo Oyj Earnings Call Transcript: Q2 2026
Revenue, EBIT, and EPS declined year-over-year amid weak demand, especially in occupational healthcare, but consumer and dental segments showed growth. Guidance for full-year adjusted operating profit was lowered, with recovery expected to be gradual and major gains postponed to 2027.
Terveystalo Oyj Quarterly report: Q2 2026
Terveystalo Oyj has published its Q2 2026 quarterly earnings report on July 17, 2026.
Terveystalo Oyj Slides: Q2 2026
Terveystalo Oyj has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 17, 2026.
Terveystalo Oyj Transcript: M&A announcement
A major acquisition will create a leading European outpatient care platform, combining complementary strengths in healthcare and eye care, with strong financials, significant synergies, and robust shareholder support. The deal accelerates growth, diversifies revenue, and positions the group for future innovation and expansion.
Terveystalo Oyj Press release: M&A announcement
Terveystalo Oyj issued a press release on June 8, 2026, disclosing material business information to investors.
Terveystalo Oyj Slides: M&A announcement
Terveystalo Oyj has posted slides in relation to its latest quarterly earnings report, which was published on June 8, 2026.
Terveystalo Oyj Slides: M&A announcement
Terveystalo Oyj has posted slides in relation to its latest quarterly earnings report, which was published on June 8, 2026.
Terveystalo Oyj Press release: M&A announcement
Terveystalo Oyj issued a press release on June 8, 2026, disclosing material business information to investors.
Terveystalo Oyj Earnings Call Transcript: Q1 2026
Revenue and profitability declined sharply in Q1 2026 amid an exceptionally weak healthcare market, but operational efficiency and digital investments remained strong. Management expects gradual recovery from H2, with full-year EBIT guidance maintained and key growth initiatives underway.
Terveystalo Oyj Quarterly report: Q1 2026
Terveystalo Oyj has published its Q1 2026 quarterly earnings report on April 24, 2026.
Terveystalo Oyj Slides: Q1 2026
Terveystalo Oyj has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 24, 2026.
Terveystalo downgraded to Hold from Buy at SEB Equities
SEB Equities analyst Anssi Raussi downgraded Terveystalo (TTALF) to Hold from Buy with a EUR 10.70 price target The firm cites the company’s weaker than expected outlook for the downgrade.
Terveystalo Oyj Earnings Call Transcript: Q4 2025
All-time high profitability and efficiency achieved despite revenue declines and market headwinds. 2026 guidance reflects a wide range due to macro and seasonal uncertainties, with investments in digital transformation and M&A supporting future growth.
Terveystalo Oyj Annual report: Q4 2025
Terveystalo Oyj has published its Q4 2025 annual report on February 13, 2026.
Terveystalo Oyj Quarterly report: Q4 2025
Terveystalo Oyj has published its Q4 2025 quarterly earnings report on February 13, 2026.
Terveystalo Oyj Slides: Q4 2025
Terveystalo Oyj has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 13, 2026.
Terveystalo Oyj Slides: FY 2025
Terveystalo Oyj has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 19, 2025.